ECDC comments on two studies published on 14 October 2015 in the New England Journal of Medicine provide insights into sexual transmission of Ebola virus and the duration of virus persistence in semen.
The peer-review visits identified some common good practices as well as a large degree of similarity in the challenges faced in preparing for possible Ebola cases.
Despite a dramatic improvement of the epidemiological situation in Guinea in 2015, the elimination of human transmission of the Ebola virus will require sustained efforts over the next few months. ECDC will continue deploying experts to Guinea to contribute to the field work related to surveillance and response activities, under the World Health Organization's Global Outbreak Alert and Response Network (GOARN) umbrella.
Results from a recent vaccine trial, conducted by collaborating health authorities, possibly represent a major breakthrough in the control of Ebola virus disease.
Every year, around 50 000 newly diagnosed cases of hepatitis B and C are reported across Europe but millions are unaware of their infection. Left untreated, hepatitis can cause irreversible liver damage. Hepatitis A is recognised as a re-emerging health threat in Europe.
On 12 May 2015, Italian authorities informed about a confirmed case of Ebola Virus Disease (EVD) in a healthcare worker who recently returned from Sierra Leone after working in an EVD treatment centre from 15 February to 6 May 2015.
A report published on 1 May indicates that the Ebola virus can persist in seminal fluid of a person who recovered from Ebola virus disease for longer than previously known and can potentially lead to sexual transmission of Ebola virus.
On the occasion of the tenth anniversary of European Immunization Week, ECDC is releasing a new complement of data, tools, blogs and updates to support public health authorities in their work against vaccine preventable diseases.